We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 79 days · 79 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 79 days • 1 price levels
Price Analysis
Most common price: £490 (79 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 79 days
Description
Key Features
Provides latent demand outlook and potential industry earnings estimates for exocrine pancreatic insufficiency therapeutics through 2028.
Includes detailed data across 10,833 specific US zip codes to support highly localized market analysis.
Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the entire United States.
Supports distribution and sales strategies through granular statistical data and geographic market segmentation.
Delivers precise potential industry earnings (P.I.E.) estimates measured in millions of U.S. dollars.
Product Specifications
- Format
- paperback
- ASIN
- B0BSJC3LY7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
Exocrine Pancreatic Insufficiency Therapeutics India Outlook
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
Pancreatic Cancer Drug Outlook: Africa & Middle East Study
Pancreatic Cancer Drug Outlook in Latin America 2013-2018
Pancreatic Cancer Drug Outlook 2013-2018 - North America
Pancreatic Cancer Drug Outlook in Europe 2013-2018 Study
The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
Pancreatic Cancer Drug Outlook in Africa 2011-2016 Study
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
Multidisciplinary Management of Acute and Chronic Pancreatitis
IntechOpen
Peptides and Heparin for Diabetes Outlook 2023-2028 Study
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
2023-2028 Pen Insulin Syringes US Zip Code Market Outlook
Chronic Pancreatitis
IntechOpen
DPP-IV Inhibitors in Europe 2013-2018 Econometric Study
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
Chronic Pancreatitis: From Basic Research to Clinical Treatment
Springer
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
Pancreatic Islet Cell Regeneration and Growth: Proceedings of a Diabetes Institute Conference Held in Norfolk, Virginia, June 22-23, 1991: v. 321 (Advances in Experimental Medicine and Biology)
Springer